SemperVirens
About SemperVirens
Sempervirens Fund is California’s oldest land trust, established in 1900, dedicated to protecting and restoring coast redwood forests in the Santa Cruz Mountains. As a 501(c)(3) nonprofit organization based in Los Altos, California, its mission focuses on preserving wildlife habitats, watersheds, and natural features while promoting public appreciation of these environments. Over its 125 years of operation, the Fund has protected approximately 35,000 to 36,000 acres of redwood land through land acquisition, conservation easements, and trail linkages.
The Fund engages in various core activitie
SemperVirens Venture Capital was founded in 2018 by Greg Golub and Robby Peters. Stephan Roche has been named chief executive. In December 2025 the firm promoted Colin Tobias to general partner and Raquel Scott to principal. Allison Baum Gates is also listed as a general partner. In March 2025 the firm announced it had closed $177 million across new funds for early-stage B2B companies. One third-party listing names a fund called SemperVirens Core Fund III, but no size for that fund is public. The firm's LinkedIn page shows 11 to 50 employees.
The firm describes itself as an ecosystem-driven venture firm that invests in AI solutions for complex markets in health, wealth and work. It looks for AI-native companies that target large, complicated service markets, and it offers founders help with multi-channel distribution through an enterprise executive network. In 2025 it launched an accelerator focused on go-to-market strategy and access to decision-makers. Recent AI rounds include Take2, an AI agents platform for healthcare recruiting, which raised a $14 million Series A in February 2026 with SemperVirens VC participating. In May 2026, 9amHealth raised a $26 million Series B for AI-driven virtual specialty care, with SemperVirens taking part.
Public listings disagree on stage and check size. One profile lists pre-seed, seed and Series A investments, with tickets of $0 to $1 million. Another lists checks of $500K to $5M. The firm has also backed later rounds, including a $55 million Series C for Stepful in June 2026 and a $40 million Series B for Thatch Health.
- Sully AI: clinical AI company; the firm was a co-investor in its Series A in March 2026.
- Take2: AI agents platform for healthcare recruiting; $14 million Series A in February 2026.
- 9amHealth: AI-driven virtual specialty care for chronic conditions; $26 million Series B in May 2026.
- sempervirensvc.com
- linkedin.com/company/sempervirensvc
- f4.fund/firms/sempervirens-venture-capital
- globalfintechseries.com/investment-services/sempervirens-strengthens-i
- superscout.co/investor/sempervirens-venture-capital
- pulse2.com/sempervirens-177-million-closed-across-two-new-funds
- leadiq.com/c/sempervirens-venture-capital/5df3dd0be9af50bb74a14d46
- caplight.com/investor/sempervirens-vc
Investing activity
SemperVirens appears in 2 AI deals tracked by the AI Lounge deals desk, rounds totalling $110M, and led 1 of them. The rounds are mostly Series A, with a median round size of $10M. The most recent are Collective (Series B and growth facility, $100M, Oct 2026) and UpSmith (Series A, $10M, Oct 2026).
SemperVirens most often invests alongside General Catalyst, QED Investors, Gradient Ventures and FT Partners, and the companies it backs on AI Lounge are mostly in AI financial operating system for solo businesses and AI agents / home services.
Deals
Frequently asked questions about SemperVirens
When was SemperVirens Venture Capital founded and who started it?
The firm was founded in 2018 by Greg Golub and Robby Peters. Stephan Roche has since been named chief executive.
How big are SemperVirens funds?
The firm announced in March 2025 that it had closed $177 million across new funds. Individual fund sizes are not public, and third-party AUM estimates vary.
What stages does SemperVirens VC invest in?
Some public profiles list pre-seed, seed and Series A investments. The firm has also backed later rounds, such as a Series C for Stepful in June 2026.
Which AI startups has SemperVirens VC backed?
Recent examples include Take2, an AI agents platform for healthcare recruiting, which raised a $14 million Series A in February 2026, and Sully AI, a clinical AI company.
Where is SemperVirens VC headquartered?
Most public listings place the firm in San Mateo, California, although Crunchbase lists Mountain View.
What AI companies has SemperVirens invested in?
SemperVirens's AI investments include UpSmith. The 2 rounds on AI Lounge are listed on this page with amounts, dates and co-investors.
Where is SemperVirens based?
SemperVirens is based in Mountain View, California, United States.
What stage does SemperVirens invest at?
In the rounds tracked on AI Lounge, SemperVirens has invested at Series A, with a median round of $10M. SemperVirens led 1 of those rounds.
Who does SemperVirens co-invest with?
SemperVirens's most frequent co-investors on AI Lounge are General Catalyst (1 deal), QED Investors (1 deal), Gradient Ventures (1 deal), FT Partners (1 deal) and Intuit Ventures (1 deal).
How can founders reach SemperVirens?
Founders on AI Lounge can see SemperVirens's contact details in AI Investor Contacts (paid plans), check for a warm introduction through members who worked with the firm under Warm Paths, and add SemperVirens to their Investor Pipeline to track the conversation.